These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 2386305)

  • 1. [Methoxyflurane and ethanol do not inhibit the neuronal uptake of noradrenaline (uptake 1) at the desipramine binding site].
    Kress HG; Schömig E
    Anaesthesist; 1990 Jul; 39(7):371-4. PubMed ID: 2386305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Volatile anesthetics and n-alcohols inhibit the uptake of noradrenaline in pheochromocytoma cells].
    Tas PW; Kress HG; Koschel K
    Anaesthesist; 1987 Jul; 36(7):340-4. PubMed ID: 3661947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of neuronal noradrenaline uptake (uptake1) and desipramine binding by N-ethylmaleimide (NEM).
    Schömig E; Michael-Hepp J; Bönisch H
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jun; 337(6):633-6. PubMed ID: 3216896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereoselective uptake of atenolol into storage granules isolated from PC12 cells.
    Bagwell EE; Webb JG; Walle T; Gaffney TE
    J Pharmacol Exp Ther; 1989 May; 249(2):476-82. PubMed ID: 2724136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The transport of (+)-amphetamine by the neuronal noradrenaline carrier.
    Bönisch H
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Oct; 327(4):267-72. PubMed ID: 6514010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conclusive evidence for distinct transporters for 5-hydroxytryptamine and noradrenaline in pulmonary endothelial cells of the rat.
    Paczkowski NJ; Vuocolo HE; Bryan-Lluka LJ
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Mar; 353(4):423-30. PubMed ID: 8935709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of 3H-desipramine to the neuronal noradrenaline carrier of rat phaeochromocytoma cells (PC-12 cells).
    Bönisch H; Harder R
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Dec; 334(4):403-11. PubMed ID: 3821933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of xylamine binding to proteins of PC12 pheochromocytoma cells.
    Koide M; Cho AK; Howard BD
    J Neurochem; 1986 Oct; 47(4):1277-85. PubMed ID: 3746302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amezinium and debrisoquine are substrates of uptake1 and potent inhibitors of monoamine oxidase in perfused lungs of rats.
    Bryan-Lluka LJ; Seers H; Sharpe I
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):536-44. PubMed ID: 8740147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catechol-O-methyltransferase activity in CHO cells expressing norepinephrine transporter.
    Percy E; Kaye DM; Lambert GW; Gruskin S; Esler MD; Du XJ
    Br J Pharmacol; 1999 Oct; 128(3):774-80. PubMed ID: 10516661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of serotonin uptake in cultured pheochromocytoma cells. Comparison with norepinephrine uptake.
    Yoffe JR; Borchardt RT
    Mol Pharmacol; 1982 Mar; 21(2):368-73. PubMed ID: 7099140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xylamine, an irreversible inhibitor of norepinephrine uptake, is transported by this same uptake mechanism in cultured rat superior cervical ganglia.
    Fischer JB; Waggaman LA; Ransom RW; Cho AK
    J Pharmacol Exp Ther; 1983 Sep; 226(3):650-5. PubMed ID: 6887005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of neuronal noradrenaline transport (uptake1) and desipramine binding by amiloride and ethylisopropylamiloride.
    Schömig E; Michael-Hepp J; Schönfeld CL
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Nov; 340(5):495-501. PubMed ID: 2559331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [3H]mazindol binding associated with neuronal dopamine and norepinephrine uptake sites.
    Javitch JA; Blaustein RO; Snyder SH
    Mol Pharmacol; 1984 Jul; 26(1):35-44. PubMed ID: 6087116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic evidence for a common binding site for substrates and inhibitors of the neuronal noradrenaline carrier.
    Schömig E; Körber M; Bönisch H
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jun; 337(6):626-32. PubMed ID: 2851105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual effects of intravenous anesthetics on the function of norepinephrine transporters.
    Hara K; Yanagihara N; Minami K; Hirano H; Sata T; Shigematsu A; Izumi F
    Anesthesiology; 2000 Nov; 93(5):1329-35. PubMed ID: 11046223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-site model of the neuronal 5-hydroxytryptamine uptake and imipramine-binding site.
    Marcusson JO; Bäckström IT; Ross SB
    Mol Pharmacol; 1986 Aug; 30(2):121-8. PubMed ID: 3016498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of transport function and desipramine binding at the human noradrenaline transporter by N-ethylmaleimide and protection by substrate analogs.
    Foley KF; Cozzi NV
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Jun; 365(6):457-61. PubMed ID: 12070759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carrier-mediated outward transport of noradrenaline from adrenergic varicosities.
    Trendelenburg U
    Pol J Pharmacol Pharm; 1990; 42(6):515-20. PubMed ID: 2103002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the human norepinephrine transporter by cocaine and amphetamine.
    Zhu MY; Shamburger S; Li J; Ordway GA
    J Pharmacol Exp Ther; 2000 Dec; 295(3):951-9. PubMed ID: 11082428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.